A recent article in The Washington Post demonstrates that when opioid medications become less available to veterans, suicide rates go up. And not by a little. This only serves to further show the extent of damage done by foolish U.S. drug policies.
Genes in three different pathways were differentially expressed between veterans who attempted suicide and those who had not. One of the genetic pathways that showed substantial disruption is known as mTOR, the dysregulation of which has been previously linked to major depressive disorder.
Director of Medicine Dr. Jamie Wells attended the annual Yale-West Point Civil-Military Service Symposium, where issues of veterans health policy were extensively discussed.